ASCO 2020: Updates in renal cancer

TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy

Highlights from ASCO 2020

Timing of response to venetoclax combination treatment in older patients with acute myeloid leukaemia

Ensuring quality care for breast cancer patients globally

Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma

Denosumab in multiple myeloma patients with renal insufficiency

Maintenance avelumab plus best supportive care (BSC) versus BSC alone after chemotherapy in advanced urothelial carcinoma

Better genetic diagnostics in Ugandan breast cancer patients

Cisplatin plus/minus veliparib in metastatic TNBC and/or germline BRCA-associated breast cancer

Update from KAITLIN for high-risk HER2-positive early breast cancer

CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma